A captivating cricket match unfolded between Hottentots Holland and Victoria cricket clubs in a First Division A clash, with Victoria ultimately clinching a hard-fought victory at the Naval Sports ...

In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare ...

Read Our Latest Stock Report on SRPT Sarepta Therapeutics Stock Down 0.3 % Shares of NASDAQ SRPT opened at $111.82 on Thursday. Sarepta Therapeutics has a 1 year low of $102.15 and a 1 year high ...

In a report released yesterday, Kostas Biliouris from BMO Capital maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), with a price target of $200.00. Kostas Biliouris has ...

Sarep­ta Ther­a­peu­tics un­veiled new re­sults from the sec­ond part of a clin­i­cal tri­al for its Duchenne mus­cu­lar dy­s­tro­phy gene ther­a­py Ele­v­idys … ...

No new safety signals were observed. As part of a collaboration agreement signed in 2019, Sarepta is working with Roche Holdings AG RHHBY. Sarepta is responsible for regulatory approval and ...

Sarepta (SRPT) announced topline results from Part 2 of EMBARK, a global, randomized, double-blind, placebo-controlled, Phase 3 clinical study of Elevidys, the only approved gene therapy in ...

Rare disease specialist Sarepta Therapeutics has joined with Selecta Biosciences in a research pact to develop ways to allow its gene therapies to be re-dosed. Sarepta is developing gene ...

Getty Images/Pedro H. Tesch Coming off a victory over Internacional last week, Mexico visit River Plate at the Estadio Monumental in Buenos Aires, Argentina, to put an end to their adventure in ...